InvestorsHub Logo

drkazmd65

10/30/14 2:33 PM

#103064 RE: JG36 #103062

I will disagree somewhat with your points JG.

It is a gamble - both positive and negative aspects you state are generally in line with what I would expect.

IF this Ebolacide2 gambit pays off as you outline (and as many here suspect) and is a success in the upcoming USAMRIID tests - we could easily see a spike in shareprices that would both make the company look good to additional investors, and allow Flucide (or Denguecide, or HIVcide,....) work to progress with far less need to run dilutive financing like selling stock.

This would also serve as one heck of a good bit of amazing PR for NNVC and for it's virus-treatment development platform.

IF the Ebolacide2 gambit doesn't pay off as you outline then yes - we should expect to see the shareprices here take a short-term hit. We could see shareprices drop down lower than we have seen them drop even at the height of the Pump Terminator hype last Winter/Spring. That would (indeed) impact how further funding (via dilutive share-sales) would have to be done and how dilutive that might be to current shareholders.

Personally - if the 2nd scenario is what we end up with (and I view this as a substantial probability, but not a high likelihood) then I will continue to ride out Flucide development, TOX, and Phase I/II testing - barring bad news on that front as well.

I (in fact) will most likely look to average down when I think NNVC has somewhat bottomed out and add to what I hold if we see Ebolacide2 not come up to expectations, but Flucide progress being made despite the Ebolacide hang-up.

As I said - I don't view (and others will disagree of course) Ebolacide2 as the prize here in the long-term. My eye remains on Flucide as in the long-run that's where the real money is to be made.

BonelessCat

10/30/14 3:08 PM

#103066 RE: JG36 #103062

This is Bird Flu redux, and not in the way some here might think. Bird Flu was a hot research area until the first treatment was approved for market. It had already faded as an epidemic, but nothing stopped until Tamiflu was approved for market.

This time around, a treatment for ebola will be found even if the epidemic burns out. It has threatened and frightened the developed world enough that research will not stop until an effective vaccine or treatment is found and approved. There will be something, and at this point EbolaCide has the same chances as any vaccine or treatment.

A note on vaccines, if the J&J sickens even one westerner, the search continues. If it's effective, ebola game over.

L vus

10/30/14 5:48 PM

#103072 RE: JG36 #103062

WRONG!!! When Ebolacide2 is tested by the Army and found to eradicate Ebola,there is a ton of money waiting on NNVC to produce Ebolacide2. Dr Seymour is going to request 100,000,000 from our Govt. The United Nations is trying to raise 1,000,000,000 to fund a world wide effort to eradicate Ebola. There is a lot of cash waiting for Ebolacide2 and any other company who shows the ability to clear up Ebola.

Another neat reason to have the Army on our side is that when the Army decides to test in humans and Ebolacide2 is proven, the Army trumps the FDA and goes straight to human testing and the platform is on its way cutting out a lot of time. Each Cide will be approved in less than 6 mo. and viruses will be history.

If you think this is far fetched then think again. The Army is sending 6000 soldiers to West Africa in harms way. You know the Army is scrambling to test and approve Ebolacide2 for the safety of our troops.

L vus